The objective of this study is to explore the dynamics of two different industries -pharmaceuticals and investment funds.
Despite their different purposes, both sectors are facing significant challenges in terms of consumer confidence, which have been exacerbated by recent major crises. Our analysis focuses on the impact of regulation and technology on consumer protection and industry growth, drawing similarities between their complex ecosystems and shedding light on their common opportunities and pitfalls.
